bpc 157 human clinical trials systematic review BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers How does the peptide BPC-157
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Shanina E, Liao B, Smith RG
The Methylmalonyl-CoA Reaction: B12 is also needed by another enzyme (methylmalonyl-CoA mutase) inside the cells power plants (mitochondria)
FDA-Approved Uses The FDA has approved cyanocobalamin for treating vitamin B12 deficiency
Independent third-party testing via Janoshik in progress
PMC Early clinical safety work: Phase 1/2 investigations with T4 examined IV/topical use and general tolerability, but did not establish approved indications
